Loading clinical trials...
Loading clinical trials...
An Investigator Initiated Study to Evaluate the Efficacy of Baricitinib In Treatment of Delayed-Type Hypersensitivity Versus Irritant Skin Reactions In Healthy Adult Male Subjects
Conditions
Interventions
Baricitinib
Placebo
Locations
1
United States
Wright State Physicians
Fairborn, Ohio, United States
Start Date
September 14, 2020
Primary Completion Date
October 16, 2023
Completion Date
October 16, 2023
Last Updated
December 5, 2023
NCT06957444
NCT05498467
NCT05858723
NCT04365140
NCT03309215
NCT03902392
Lead Sponsor
Wright State Physicians
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions